ERNA
NASDAQ · Biotechnology
Ernexa Therapeutics Inc
$7.03
+0.06 (+0.86%)
Open$6.66
Previous Close$6.97
Day High$7.25
Day Low$6.51
52W High$71.50
52W Low$3.18
Volume—
Avg Volume70.6K
Market Cap7.58M
P/E Ratio—
EPS$-25.77
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+337.7% upside
Current
$7.03
$7.03
Target
$30.77
$30.77
$21.48
$30.77 avg
$35.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 18.39M | 59.60M | 759.7K |
| Net Income | -1,407,587,770 | -4,105,084,228 | -24,634 |
| Profit Margin | -7,652.8% | -7,270.1% | -3.2% |
| EBITDA | -1,182,760,510 | -3,641,032,030 | -38,889 |
| Free Cash Flow | — | — | -29,815 |
| Rev Growth | -69.1% | -69.1% | +6.1% |
| Debt/Equity | — | — | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $254.31 | +0.38% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $360.55 | +0.62% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.33 | -1.21% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $499.65 | +1.69% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $631.81 | -0.17% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.52 | +0.74% | 69.3 | 39.97B |